
Kismet Technologies: Innovating material tech for long-lasting, pathogen-free surfaces.
Founded with a mission to enhance public health through advanced material technologies, Kismet Technologies focuses on creating safe infection control solutions. The company's core product, NanoRAD, is a groundbreaking material technology that provides long-lasting pathogen-free surfaces by continuously releasing hydrogen peroxide. This innovation aims to reduce the frequency of illnesses by ensuring surfaces remain disinfected long after application. Kismet Technologies targets markets that require stringent hygiene standards, such as healthcare, hospitality, and public transportation.
Kismet Technologies has garnered attention for its innovative approach to infection control, attracting notable investors and industry experts. The company's key achievements include the successful development and commercialization of NanoRAD, which has been recognized for its efficacy in providing continuous antimicrobial protection. Through its pioneering work, Kismet Technologies has made a significant impact on public health and safety, offering a reliable solution to combat the spread of infectious diseases on high-touch surfaces.

NanoGuard Technologies

Singletto
singletto.com

Kinnos
kinnos.com

Aionx Antimicrobial Technologies
aionx.com

Hygienica
hygienica.net

AvantGuard
avantguardinc.com

Helios Innovative Technologies

4ME4WE

Micron Pure
micronpure.com

NanoTouch Materials

Zylast
zylast.com

Applied UV
applieduvinc.com

Tomi Environmental Solutions
steramist.com

It's Nanoed

Fathhome
fathhome.net
Companies similar to Kismet Technologies include NanoGuard Technologies, Singletto, Kinnos and Aionx Antimicrobial Technologies.
Kismet Technologies was founded in 2019.
Kismet Technologies' headquarters is located in Orlando, FL, US.
Kismet Technologies' most recent funding round was for $5M (USD) in August 2023.
As of Aug 1, 2023, Kismet Technologies has raised a total of $9.3M (USD).
Kismet Technologies has 8 employees as of Feb 4, 2024.